• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

National Action Plan in Antimicrobial Resistance Using Framework Analysis for China.

作者信息

Chen Shanquan, Zhang Jiahong, Wu Yongning

机构信息

School of Humanity and Social Science, School of Medicine, School of Data Science, The Chinese University of Hong Kong, Shenzhen, Shenzhen City, Guangdong Province, China.

NHC Key Laboratory of Food Safety Risk Assessment, China National Center for Food Safety Risk Assessment, Research Unit of Food Safety, Chinese Academy of Medical Sciences, Beijing, China.

出版信息

China CDC Wkly. 2023 Jun 2;5(22):492-498. doi: 10.46234/ccdcw2023.093.

DOI:10.46234/ccdcw2023.093
PMID:37408616
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10318557/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fce/10318557/fe7101132f44/ccdcw-5-22-492-S1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fce/10318557/cf20c1f72d2f/ccdcw-5-22-492-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fce/10318557/f1e1a38c5b13/ccdcw-5-22-492-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fce/10318557/fe7101132f44/ccdcw-5-22-492-S1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fce/10318557/cf20c1f72d2f/ccdcw-5-22-492-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fce/10318557/f1e1a38c5b13/ccdcw-5-22-492-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4fce/10318557/fe7101132f44/ccdcw-5-22-492-S1.jpg

相似文献

1
National Action Plan in Antimicrobial Resistance Using Framework Analysis for China.《中国基于框架分析的抗菌药物耐药性国家行动计划》
China CDC Wkly. 2023 Jun 2;5(22):492-498. doi: 10.46234/ccdcw2023.093.
2
Control of antimicrobial resistance in Cameroon: Feasibility of implementing the National Action Plan.喀麦隆抗菌药物耐药性控制：实施国家行动计划的可行性。
Trop Med Int Health. 2021 Oct;26(10):1231-1239. doi: 10.1111/tmi.13649. Epub 2021 Jul 26.
3
Unpacking multi-level governance of antimicrobial resistance policies: the case of Guangdong, China.解析抗微生物药物耐药性政策的多层次治理：以中国广东为例。
Health Policy Plan. 2022 Oct 12;37(9):1148-1157. doi: 10.1093/heapol/czac052.
4
Impact of the National Action Plan for Antimicrobial Resistance on Antibiotic Use for Mastitis Using a Japanese Nationwide Database.利用日本全国性数据库评估《国家抗微生物药物耐药性行动计划》对乳腺炎抗生素使用的影响
Breast Care (Basel). 2023 May;18(2):122-129. doi: 10.1159/000529381. Epub 2023 Jan 27.
5
Outcomes and Future Prospect of Japan's National Action Plan on Antimicrobial Resistance (2016-2020).日本《抗菌药物耐药性国家行动计划（2016 - 2020年）》的成果与未来展望
Antibiotics (Basel). 2021 Oct 22;10(11):1293. doi: 10.3390/antibiotics10111293.
6
The effects of Japan's National Action Plan on Antimicrobial Resistance on antimicrobial use.日本国家行动计划对抗微生物药物耐药性的影响对抗微生物药物的使用的影响。
Int J Infect Dis. 2021 Feb;103:154-156. doi: 10.1016/j.ijid.2020.11.158. Epub 2020 Nov 20.
7
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications.巴基斯坦抗菌药物耐药性国家行动计划进展：叙述性综述及影响
Expert Rev Anti Infect Ther. 2022 Jan;20(1):71-93. doi: 10.1080/14787210.2021.1935238. Epub 2021 Jul 26.
8
Evaluation of the global action plan on antimicrobial resistance in Japan during its first eighteen months.日本抗菌药物耐药性全球行动计划头18个月的评估
Drug Discov Ther. 2018;12(3):182-184. doi: 10.5582/ddt.2018.01011.
9
National Action Plan on Antimicrobial Resistance (AMR) 2016-2020 and relevant activities in Japan.《2016 - 2020年国家抗微生物药物耐药性行动计划》及日本的相关活动
Glob Health Med. 2019 Dec 31;1(2):71-77. doi: 10.35772/ghm.2019.01017.
10
National action plan of the Islamic Republic of Iran for combating antimicrobial resistance during 2016 - 2021.伊朗伊斯兰共和国2016 - 2021年抗菌药物耐药性防治国家行动计划。
Med J Islam Repub Iran. 2018 Aug 2;32:65. doi: 10.14196/mjiri.32.65. eCollection 2018.

引用本文的文献

1
Association between depressive symptoms and smoking intensity with ethnic minorities in Yunnan Province, China: a moderated mediation model.中国云南省少数民族抑郁症状与吸烟强度之间的关联：一个有调节的中介模型。
BMC Psychol. 2025 Aug 19;13(1):940. doi: 10.1186/s40359-025-03278-8.
2
What Are the Drivers Triggering Antimicrobial Resistance Emergence and Spread? Outlook from a One Health Perspective.引发抗菌药物耐药性出现和传播的驱动因素有哪些？“同一健康”视角下的展望。
Antibiotics (Basel). 2025 May 26;14(6):543. doi: 10.3390/antibiotics14060543.
3
Evolving patterns of healthcare-associated infections in NICU: a five-year retrospective analysis from a tertiary children's hospital in China.

本文引用的文献

1
An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.对现有的国家抗菌素耐药行动计划的分析——在优化人群中抗生素使用的策略方面存在的差距和机遇。
Lancet Glob Health. 2023 Mar;11(3):e466-e474. doi: 10.1016/S2214-109X(23)00019-0. Epub 2023 Feb 2.
2
Antibiotic Stewardship in Retail Pharmacies and the Access-Excess Challenge in China: A Policy Review.中国零售药店的抗生素管理与获取-过度使用挑战：政策综述
Antibiotics (Basel). 2022 Jan 21;11(2):141. doi: 10.3390/antibiotics11020141.
3
Over-the-counter antibiotic sales in community and online pharmacies, China.
新生儿重症监护病房医院感染的演变模式：来自中国一家三级儿童医院的五年回顾性分析
Eur J Clin Microbiol Infect Dis. 2025 Mar 23. doi: 10.1007/s10096-025-05103-x.
4
Implementing the Chinese mandatory antimicrobial stewardship program: barriers to continuous improvement.实施中国强制性抗菌药物管理计划：持续改进的障碍
Health Policy Plan. 2025 Jun 12;40(6):591-599. doi: 10.1093/heapol/czaf019.
5
Epidemiology and Antimicrobial Resistance of Stenotrophomonas maltophilia in China, 2014-2021.2014 - 2021年中国嗜麦芽窄食单胞菌的流行病学及抗菌药物耐药性
Infect Dis Ther. 2025 Jan;14(1):261-274. doi: 10.1007/s40121-024-01099-7. Epub 2024 Dec 28.
6
Metagenomics insights into bacterial diversity and antibiotic resistome of the sewage in the city of Belém, Pará, Brazil.宏基因组学揭示巴西帕拉州贝伦市污水中细菌多样性及抗生素耐药组情况
Front Microbiol. 2024 Nov 19;15:1466353. doi: 10.3389/fmicb.2024.1466353. eCollection 2024.
7
Synergistic efficacy of ZnO quantum dots, Ag NPs, and nitazoxanide composite against multidrug-resistant human pathogens as new trend of revolutionizing antimicrobial treatment.氧化锌量子点、银纳米颗粒和硝唑尼特复合物对多重耐药人类病原体的协同疗效——抗菌治疗变革的新趋势
Discov Nano. 2024 Oct 3;19(1):164. doi: 10.1186/s11671-024-04085-7.
8
Antibiotic Residues, Antimicrobial Resistance and Intervention Strategies of Foodborne Pathogens.食源性病原体的抗生素残留、抗菌药物耐药性及干预策略
Antibiotics (Basel). 2024 Apr 2;13(4):321. doi: 10.3390/antibiotics13040321.
中国社区和在线药店的非处方抗生素销售。
Bull World Health Organ. 2020 Jul 1;98(7):449-457. doi: 10.2471/BLT.19.242370. Epub 2020 Apr 21.
4
The role of vaccines in fighting antimicrobial resistance (AMR).疫苗在对抗抗微生物药物耐药性（AMR）中的作用。
Hum Vaccin Immunother. 2018;14(9):2142-2149. doi: 10.1080/21645515.2018.1476814. Epub 2018 Jul 9.
5
Bioindustry in China: An overview and perspective.中国生物产业：综述与展望。
N Biotechnol. 2018 Jan 25;40(Pt A):46-51. doi: 10.1016/j.nbt.2017.08.002. Epub 2017 Aug 19.
6
Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.耐甲氧西林金黄色葡萄球菌和耐万古霉素肠球菌：治疗现状与前景
Lancet. 1997 Jun 28;349(9069):1901-6. doi: 10.1016/s0140-6736(96)11192-2.